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ABSTRACT
A real-time PCR assay for Clostridium difﬁcile was
developed, based on the tcdB gene, which detec-
ted all known toxinogenic reference strains
(n = 45), within 30 serogroups and 24 toxinotypes.
The analytical sensitivity was 1 · 103 CFU ⁄mL,
and the detection limit in faeces was 1 · 105
CFU ⁄g. The optimal protocol for DNA extraction
from faecal samples involved use of the Magna-
Pure system with a Stool Transport and Recovery
(STAR) buffer pre-treatment. In a 1-month pros-
pective study of 85 patients with diarrhoea, the
sensitivity, speciﬁcity and positive and negative
predictive values of the assay were 100%, 94%,
55% and 100%, respectively, compared with the
standard cell cytotoxicity assay.
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Clostridium difﬁcile has been recognised as the
causative agent of antibiotic-associated diarrhoea
(CDAD) and pseudomembranous colitis (PMC).
Enteropathogenicity depends on the production
of enterotoxin A (TcdA; 308 kDa) and cytotoxin B
(TcdB; 270 kDa) [1,2]. TcdA has been regarded as
the most important factor causing enteropatho-
genic disease [3,4], but there have been an
increasing number of reports of disease caused
by TcdA-negative, TcdB-positive strains [5].
Therefore, the present study designed a real-time
PCR assay for tcdB to enable rapid diagnosis of
CDAD associated with toxinogenic C. difﬁcile. An
optimal DNA extraction protocol for faecal sam-
ples was established, and an internal control was
included to verify ampliﬁcation.
Primers and probe (Table 1) were designed
from the non-repeat region of a known tcdB
sequence (accession no. X53138) using the Primer3
program (http://www.broad.mit.edu/cgi-bin/
primer/primer3_www.cgi). Ampliﬁcation reac-
tions were performed in a 50-lL ﬁnal volume, con-
taining 25 lL IQ Supermix (Bio-Rad, Veenendaal,
The Netherlands), 5 pmol forward primer,
10 pmol reverse primer, 4 mM MgCl2, 0.2 lM
probe, and 5 lL DNA extract. Following an
enzyme activation step for 3 min at 95C, ampli-
ﬁcation comprised 50 cycles of 30 s at 94C, 30 s at
57C and 30 s at 72C in an iCycler IQ real-time
detection system (Bio-Rad). The assay was optim-
ised using C. difﬁcile strain ATCC43594, and had
an analytical sensitivity in saline 0.9% w ⁄ v of
1 CFU ⁄PCR, corresponding to 1 · 103 CFU ⁄mL.
In addition, ten-fold dilutions of ATCC43594
(1 · 107)1 CFU) were spiked into 1 g of pooled
C. difﬁcile culture-negative faeces to determine the
sensitivity of the real-time PCR assay in compar-
ison with culture.
For C. difﬁcile culture, faecal samples, with and
without ethanol-shock treatment, were inoculated
on to selective media as described previously [6].
Colonies of Gram-positive bacilli with sub-termi-
nal spores were tested for L-proline-aminopepti-
dase production and aesculin hydrolysis [7]. Two
separate experiments revealed that the sensitivity
of the real-time PCR assay with faeces was less
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than that of culture (1 · 105 CFU ⁄ g faeces vs.
1 · 104)1 · 105 CFU ⁄ g faeces), but was compar-
able to the sensitivity (5 · 104 CFU ⁄g faeces)
reported for a real-time PCR assay described
previously [8].
To deﬁne the analytical speciﬁcity of the assay,
all known C. difﬁcile serogroups (n = 30; gift of
M. Delmee, University of Louvain, Brussels,
Belgium) and toxinotypes (n = 24; gift of M. Rup-
nik, University Goettingen, Goettingen, Germany)
were tested. All toxinogenic serogroups (n = 23)
and 22 of 24 toxinotypes were detected; two
toxinotypes (XIa and XIb) do not harbour tcdB,
and were not detected by the assay. In contrast,
Belanger et al. [8] were unable to detect tcdB in
toxinotypes III, IV and VI. This discrepancy was
associated with polymorphisms around the 3¢-
end of the primers. There were some mismatches
between the primers and probe used in the
present study and the available sequences for
TcdA– ⁄TcdB+ strains 1470 and 8864 (accession
nos. CDTOXBA and CDI011301, respectively).
Strain 1470, representing toxinotype VIII and
serogroup F, showed one mismatch with the
forward primer, but was still detected by the real-
time PCR. Strain 8864, representing toxinotype X,
showed two mismatches for both the forward
primer and the probe, and one mismatch in the
reverse primer at the 5¢-end. This strain was also
positive by the real-time PCR, but may be detect-
ed with reduced sensitivity when analysing
clinical samples. Although degenerate primers
could solve this problem, strain 8864 is a naturally
occurring isolate that has not yet been detected in
clinical samples. Nine Clostridium spp., other than
C. difﬁcile, and 27 other (including enteropatho-
genic) bacterial species were all negative accord-
ing to the assay.
Since effective DNA extraction from faecal
samples and removal of inhibitory factors is a
key factor in successful application of PCR [9],
polyvinylpolypyrolidone (PVPP) pre-treatment,
followed by isolation using the QIAamp DNA
blood mini kit (Qiagen, Hilden, Germany) was
compared with pre-treatment using the Stool
Transport and Recovery (STAR) buffer, followed
by automated extraction with the MagnaPure LC
DNA isolation Kit III (Roche, Almere, The Neth-
erlands) in the MagnaPure System (Roche). A
ﬁxed amount of Phocine Herpes Virus (PhHV), to
give a crossing point (Ct) value of c. 33–34, was
spiked into clinical samples before DNA extrac-
tion to serve as an internal control [10]. Primers
used for PhHV detection are listed in Table 1.
Although no differences in Ct values could be
observed between the two extraction methods
with faeces spiked with 2.2 · 106)22 CFU ⁄ g, and
the internal control was ampliﬁed efﬁciently in all
assays, the STAR ⁄MagnaPure method was
deemed optimal because of its automated format.
For clinical evaluation of the assay, faecal
samples were obtained from 28 patients with
CDAD. Primary diagnosis and selection was
made by detection of TcdA with an enzyme-
linked ﬂuorescent immunoassay (ELFA) (VIDAS
CDA2; bioMe´rieux, Boxtel, The Netherlands)
according to the manufacturer’s recommenda-
tions. All 28 ELFA-positive faecal samples were
also positive by real-time PCR and culture for
C. difﬁcile. When a control group of 43 faecal
samples from 43 patients without gastrointestinal
symptoms was analysed, three (7%) were positive
Table 1. Sequences of primers and
probes used for real-time PCR detec-
tion of Clostridium difﬁcile
Target Primers and probes Nucleotide sequence (5¢-3¢) Amplicon size (bp)
C. difﬁcile 398CLDs GAAAGTCCAAGTTTACGCTCAAT 177
399CLDas GCTGCACCTAAACTTACACCA
551CLD-tq-FAM FAM-ACAGATGCAGCCAAAGTTGTTGAATT-TAMRA
PhHV [10] 295PhHVs GGGCGAATCACAGATTGAATC 89
296PhHVas GCGGTTCCAAACGTACCAA
531PhHV-tq-CY5 CY5-TTTTTATGTGTCCGCCACCATCTGGATC-BHQ2
PhHV, phocine herpes virus (internal control).
Table 2. Prospective comparison of the cell cytotoxicity
assay (indicative of Clostridium difﬁcile-associated diar-
rhoea), enzyme-linked ﬂuorescent assay, real-time PCR
and culture with 85 faecal samples from patients with
diarrhoea
Clinical manifestation No. of patients
No. of positive samples
ELFA Real-time PCR
CDAD 6 5 6
Non-CDAD 79 1 5
Total 85 6 11a
CDAD, Clostridium difﬁcile-associated diarrhoea; ELFA, enzyme-linked ﬂuorescent
assay.
aAll real-time PCR-positive results were conﬁrmed by culture of toxinogenic
C. difﬁcile.
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by real-time PCR and culture, indicating asymp-
tomatic carriage of toxinogenic C. difﬁcile [11,12].
These three samples were conﬁrmed as positive
following re-extraction and re-testing by real-time
PCR.
For further clinical evaluation, 85 faecal samples
received from adult patients with a request for
C. difﬁcile testing or from patients with diarrhoea
admitted to the hospital for ‡3 days were investi-
gated prospectively (Table 2). These samples were
tested initially by ELFA, and were then stored at
) 80C within 24 h pending further analysis by the
cell cytotoxicity assay and real-time PCR. Of six
(7%) samples positive by the cell cytotoxicity assay
(Table 2), ﬁve were positive by ELFA, and six by
real-time PCR. Of 79 cytotoxicity-negative sam-
ples, one was positive by ELFA and real-time PCR,
andﬁvewere positive only by real-timePCR. Thus,
11 (13%) of 85 samples were positive by real-time
PCR;C. difﬁcilewas cultured subsequently from all
these samples. Using the cytotoxicity assay as the
standard, the sensitivity, speciﬁcity and PPV and
NPV for the real-time PCR assay were 100%, 94%,
55% and 100%, respectively.
In conclusion, detection of the C. difﬁcile tcdB
gene in faecal samples by real-time PCR, using an
automated DNA extraction protocol and an inter-
nal control, can be used as a rapid method for
diagnosing CDAD and for detecting carriage in
asymptomatic patients.
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ABSTRACT
This study investigated the prevalence of methi-
cillin-resistant Staphylococcus aureus (MRSA) in
infected and uninfected diabetic foot ulcers of 84
patients with the two types of diabetes. S. aureus
was the most common pathogen among the
Gram-positive bacteria isolated from ulcers, and
almost 50% of S. aureus isolates were MRSA. The
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